Deutsche Bank Ag\ Meridian Bioscience Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$31.15 - $33.39 $1.99 Million - $2.13 Million	-63,800 Reduced 50.16%	63,388 $2.11 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $3.17 Million - $3.44 Million	102,599 Added 417.26%	127,188 $4.01 Million
Q2 2022 Aug 11, 2022	SELL	$23.75 - $31.69 $41,467 - $55,330	-1,746 Reduced 6.63%	24,589 $748,000
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $1.16 Million - $1.56 Million	-57,840 Reduced 68.71%	26,335 $684,000
Q4 2021 Feb 11, 2022	BUY	$17.46 - $21.61 $988,759 - $1.22 Million	56,630 Added 205.59%	84,175 $1.72 Million
Q3 2021 Nov 04, 2021	SELL	$17.35 - $22.5 $13,758 - $17,842	-793 Reduced 2.8%	27,545 $530,000
Q2 2021 Aug 11, 2021	SELL	$18.01 - $28.32 $43,674 - $68,676	-2,425 Reduced 7.88%	28,338 $629,000
Q1 2021 May 13, 2021	SELL	$19.76 - $29.89 $67,895 - $102,702	-3,436 Reduced 10.05%	30,763 $807,000
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $122,143 - $168,189	7,765 Added 29.38%	34,199 $639,000
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $33,173 - $64,704	2,450 Added 10.22%	26,434 $449,000
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $2.21 Million - $6.56 Million	-281,754 Reduced 92.16%	23,984 $559,000
Q1 2020 May 14, 2020	SELL	$5.57 - $11.5 $239,342 - $494,155	-42,970 Reduced 12.32%	305,738 $2.57 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $2.12 Million - $2.72 Million	268,397 Added 334.2%	348,708 $3.4 Million
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $325,021 - $425,682	-35,444 Reduced 30.62%	80,311 $759,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $526,080 - $851,012	-48,353 Reduced 29.46%	115,755 $1.37 Million
Q1 2019 May 15, 2019	BUY	$15.51 - $17.61 $675,103 - $766,510	43,527 Added 36.1%	164,108 $2.89 Million
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $2.17 Million - $2.95 Million	-149,729 Reduced 55.39%	120,581 $2.09 Million
Q3 2018 Dec 21, 2021	BUY	$14.85 - $16.35 $417,478 - $459,647	28,113 Added 11.61%	270,310 $4.03 Million
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $2.27 Million - $2.49 Million	-152,552 Reduced 38.65%	242,197 $3.61 Million
Q2 2018 Apr 21, 2020	BUY	$13.8 - $16.8 $1.19 Million - $1.45 Million	86,344 Added 28.0%	394,749 $6.28 Million
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $2.82 Million - $3.43 Million	-204,186 Reduced 39.83%	308,405 $4.9 Million
Q1 2018 Oct 18, 2019	BUY	$13.8 - $16.2 $1.65 Million - $1.94 Million	119,475 Added 30.39%	512,591 $7.28 Million
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $389,684 - $457,455	-28,238 Reduced 6.7%	393,116 $5.58 Million
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $3.04 Million - $3.54 Million	224,359 Added 113.89%	421,354 $5.9 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $2.65 Million - $2.83 Million	196,995	196,995 $2.81 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account